Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
HARPOON THERAPEUTICS INC
About HARP
Harpoon Therapeutics, Inc. is a clinical-stage immunotherapy company. The Company is engaged in the developing a T cell engager that harness the power of the body’s immune system to treat patients suffering from cancer and other diseases. T cell engagers are engineered proteins that direct a patient’s own T cells to kill target cells that express specific proteins, or antigens, carried by the target cells. The Company is developing a pipeline of T cell engagers using its TriTACs technology, focused on the treatment of solid tumors and hematologic malignancies. It has also nominated its clinical candidate using its ProTriTAC platform, a prodrug version of its TriTAC platform, designed to expand the target space for T cell engagers and bring the benefits of TriTACs to the patients. The Company’s TriTAC product candidates include HPN217, and HPN328. The Company’s ProTriTAC product candidate include HPN601, which is being developed for the treatment of multiple solid tumor indications.
Find out what a historical investment in HARPOON THERAPEUTICS INC would be worth today using our HARP stock calculator.
Market Capitalisation
-
Price-earnings ratio
-
Dividend yield
-
Volume
-
High today
-
Low today
-
Open price
-
52-week high
-
52-week low
-
Ready to start your investing journey with Stake?
Open an accountHow do I buy HARP shares in Australia?
Buying HARP shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in HARPOON THERAPEUTICS INC in minutes.
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in HARP
What is the ticker symbol of HARPOON THERAPEUTICS INC?
The ticker symbol for HARPOON THERAPEUTICS INC is HARP.
How much is one share of HARP?
One share of HARP is valued at $23.00 as of 19 May 2026.
What is the market capitalisation of HARPOON THERAPEUTICS INC HARP?
As of 19 May 2026 HARPOON THERAPEUTICS INC has a market cap of -.
What is the 52-week high for HARPOON THERAPEUTICS INC stock?
The HARPOON THERAPEUTICS INC 52-week high stock price is $NaN.
What is the 52-week low for HARPOON THERAPEUTICS INC stock?
The HARPOON THERAPEUTICS INC 52-week low stock price is $NaN.
Can I buy HARP shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy HARP shares and over 12,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in HARP on Stake
- Buy HARP from US$3 brokerage
- Invest in 9,500+ U.S. stocks and ETFs
- Own a slice of HARP from only US$10 with fractional shares
Stock shown for demonstrative purposes only. US$3 brokerage up to US$30,000.
HARP related stocks